Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Treatment of severe achalasia during pregnancy with esophagoscopic injection of botulinum toxin A: a case report

Abstract

A pregnant Thai woman presented with progressive dysphagia starting from the gestational age of 18 weeks. Total parenteral nutrition was administered at 33 weeks of gestation due to severe malnutrition. The fetus was found to be growth restricted. Preliminary diagnosis was esophageal achalasia. Diagnostic and treatment options, including early delivery followed by surgical intervention, temporizing pneumatic dilation and intrasphincteric botulinum toxin injection, were discussed before endoscopic examination. The patient preferred temporizing treatments to prolong the pregnancy and to allow for an improvement of her nutritional status to facilitate postpartum recovery. Marked dilatation of the esophagus was found during esophagoscopy. Therefore, local injection of 80 U of botulinum toxin A was chosen over balloon dilation. The swallowing function improved soon after the treatment. The patient and the fetus started to gain weight. Subsequent sonographic examinations did not show any evidence of botulinum toxicity in the fetus. The baby was born at 36 weeks of gestation with an active respiration and preserved muscle tones. Breast-feeding was withheld. The patient remained asymptomatic for at least 6 weeks after delivery. There have been reports of an intentional use of botulinum toxin in selected cases of unremitting movement disorder during pregnancy. No deleterious effects to the mothers or the babies were found in local injection with limited dosage after the first trimester. The authors cannot encourage the routine administration of this neurotoxin for the treatment of achalasia during pregnancy. However, this report provides additional information of botulinum toxin use in pregnant women.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Saksiriwuttho P, Ratanasiri T, Komwilaisak R . Fetal biometry charts for normal pregnant women in northeastern Thailand. J Med Assoc Thai 2007; 90: 1963–1969.

    PubMed  Google Scholar 

  2. Ohno J, Kawai M, Shibata Y, Arii Y . Esophageal achalasia in pregnancy. Am J Perinatol 2000; 17: 53–55.

    Article  CAS  Google Scholar 

  3. Fassina G, Osculati A . Achalasia and sudden death: a case report. Forensic Sci Int 1995; 75: 133–137.

    Article  CAS  Google Scholar 

  4. Mayberry JF, Rhodes J . Achalasia in the city of Cardiff from 1926 to 1977. J Digestion 1980; 20: 248–252.

    Article  CAS  Google Scholar 

  5. Pulanic R, Kalauz M, Opacic M, Rustemovic N, Brkic T . Successful pneumatic dilation of achalasia in pregnancy. Dig Liver Dis 2008; 40: 600–601.

    Article  CAS  Google Scholar 

  6. Leelakusolvong S, Sinpeng T, Pongprasobchai S, Tanwandee T, Kachintorn U, Manatsathit S . Effect of botulinum boxin injection for achalasia in Thai patients. J Med Assoc Thai 2006; 89: S67–S72.

    PubMed  Google Scholar 

  7. Tsui JKC . Botulinum toxin as a therapeutic agent. Pharmacol Ther 1996; 72: 13–24.

    Article  CAS  Google Scholar 

  8. Newman WJ, Davis TL, Padaliya BB, Covington CD, Gill CE, Abramovitch AI et al. Botulinum toxin type A therapy during pregnancy. Mov Disord 2004; 19: 1384–1385.

    Article  Google Scholar 

  9. Bodkin CL, Maurer KB, Wszolek ZK . Botulinum toxin type A therapy during pregnancy. Mov Disord 2005; 20: 1081–1082.

    Article  Google Scholar 

  10. Morgan JC, Iyer SS, Moser ET, Singer C, Sethi KD . Botulinum toxin during pregnancy: a survey of treating physicians. J Neurol Neurosurg Psychiatry 2006; 77: 117–119.

    Article  CAS  Google Scholar 

  11. Garza JJ, Downard CD, Clayton N, Maher TJ, Fauza DO . Clostridium botulinum toxin inhibits myometrial activity in vitro; possible application on the prevention of preterm labor after fetal surgery. J Pediatr Surg 2003; 38: 511–513.

    Article  Google Scholar 

  12. Robin L, Herman D . Botulism in pregnant woman. N Engl J Med 1996; 335: 823–824.

    Article  CAS  Google Scholar 

  13. Ravichandran E, Gong Y, Al Saleem FH, Ancharski DM, Joshi SG, Simpson LL . An initial assessment of the systemic pharmacokinetics of botulinum toxin. J Pharmacol Exp Ther 2006; 318: 1343–1351.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Wataganara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wataganara, T., Leelakusolvong, S., Sunsaneevithayakul, P. et al. Treatment of severe achalasia during pregnancy with esophagoscopic injection of botulinum toxin A: a case report. J Perinatol 29, 637–639 (2009). https://doi.org/10.1038/jp.2009.65

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2009.65

Keywords

This article is cited by

Search

Quick links